The 24 references in paper S. Al-Shukri Kh., S. Borovets Yu., M. Rybalov A., R. Saidov B., С. Аль-Шукри Х., С. Боровец Ю., М. Рыбалов А., Р. Саидов Б. (2009) “СОВРЕМЕННЫЕ МЕТОДЫ ЛОКАЛЬНОЙ ТЕРАПИИ РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ // CURRENT METHODS FOR LOCAL TREATMENT OF PROSTATE CANCER” / spz:neicon:nefr:y:2009:i:3:p:153-158

1
Cooperberg MR, Lubeck DP, Meng MV et al. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 2004; 22: 2141-2149
(check this in PDF content)
2
Ahmed HU, Pendse D, Illing R et al. Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol 2007; 4: 632-642
(check this in PDF content)
3
Eggener SE, Scardino PT, Carroll PR et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 2007; 178: 2260-2267
(check this in PDF content)
4
Zelefsky MJ, Ben-Porat L, Scher HI, Chan HM, Fearn PA and Fuks ZY et al. Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer. J Clin Oncol 2005; 23: 826
(check this in PDF content)
5
D’Amico AV, Chen MH, Roehl KA and Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 2004; 351: 125
(check this in PDF content)
6
Goto Y, Ohori M, Arakawa A, Kattan MW, Wheeler TM, Scardino PT. Distinguishing clinically im portant from unim portant prostate cancers before treatm ent: value of systematic biopsies. J Urol 1996; 156: 1059
(check this in PDF content)
7
Tsuzuki T, Hernandez DJ, Aydin H, Trock B, Walsh PC, Epstein JI. Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination. J Urol 2005; 173: 450
(check this in PDF content)
8
Naya Y, Slaton JW, Troncoso P, Okihara K and Babaian RJ. Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension. J Urol 2004; 171: 1093
(check this in PDF content)
9
Kestin LL, Goldstein NS, Vicini FA and Martinez AA. Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy. J Urol 2002; 168: 1994
(check this in PDF content)
10
Polascik TJ, Mouraviev V. Focal therapy for prostate cancer. Curr Opin Urol 2008 May; 18(3): 269-74
(check this in PDF content)
11
Chaussy C, Thuroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003; 4: 248-252
(check this in PDF content)
12
Blana A, Walter B, Rogenhofer S, Wieland WF. High- intensity focused ultrasound for the treatm ent of localized prostate cancer: 5-year experience. Urology 2004; 63: 297-300
(check this in PDF content)
13
Thueroff S, Knauer K, Chaussy C. 10 years high intensity focused ultrasound (HIFU) as local treatment of prostate cancer: profile of side effect. J Urol 2006; 175 [Suppl l]: 364
(check this in PDF content)
14
Poissonnier L, Chapelon JY, Rouviere O et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007; 51: 381-387
(check this in PDF content)
15
Spikes J.D. The origin and the meaning of the term «photodynamic» (as used in «photodynamic» therapy, for example). J. Photochem. Photobiol. 1991; 9: 369-374
(check this in PDF content)
16
Zisman A, Leibovici D, Siegel YI and Lindner A. Prostate cryoablation without an insertion kit using direct transperineal placement of ultrathin freezing probes. Tech Urol 2000; 6: 34­ 36
(check this in PDF content)
17
Zisman A, Pantuck AJ, Cohen JK and Belldegrun AS. Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template- technique and preliminary results. Urology 2001; 58: 988-993
(check this in PDF content)
18
Han KR, Belldegrun AS. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 2004; 93: 14-18
(check this in PDF content)
19
Langenhuijsen JF, Broers EM, Vergunst H. Cryosurgery for Prostate Cancer: an Update on Clinical Results of Modern Cryotechnology. Eur Urol 2009; 55:76-86
(check this in PDF content)
20
Han KR, Cohen JK, Miller RJ et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 2003; 170: 1126­ 1130
(check this in PDF content)
21
Ismail M, Ahmed S, Kastner C, Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int 2007; 100: 760-764
(check this in PDF content)
22
Bahn DK, Silverman P, Lee F et al. Focal prostate cryoablation: Initial results show cancer control and potency preservation. J Endourol 2006; 20 (9): 688-692
(check this in PDF content)
23
Onik G. Rationale for a ‘male lumpectomy,’ a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up. Cardiovasc Intervent Radiol 2008; 31: 98-106
(check this in PDF content)
24
Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J. «Male lumpectomy»: focal therapy for prostate cancer using cryoablation. Urology 2007; 70: 16 Поступила в редакцию 15.06.2009 г. Принята в печать 13.07.2009 г.
(check this in PDF content)